DermalMD Intimate Lighten Serum Formulation

THE FORMULATION Clinically Supported Brightening Complex: Evidence Based Ingredients That Work Together

Below is a readable, evidence-linked breakdown of the key brightening ingredients in this formula. When available, we reference randomized controlled trials or split-face clinical studies. Where the best available evidence is preclinical or review-level, we label it that way for accuracy.

Clinically proven ingredients at clinically studied percentages:

• Alpha Arbutin
  • What it supports: Helps improve the appearance of uneven tone by targeting melanin formation pathways.
  • Evidence: A split-face, evaluator-blinded randomized pilot study found a cream with alpha-arbutin 5% plus kojic acid 2% performed well for melasma appearance, with fewer adverse events than triple combination cream in that study context. (Combination study, not alpha-arbutin alone.)
  • PubMed: Tantanasrigul et al., J Cosmet Dermatol (PMID: 39555866)
• Niacinamide (5%)
  • What it supports: Helps improve the look of discoloration and uneven tone, partly by reducing melanosome transfer (mechanism shown in lab models) and showing visible improvements in clinical testing.
  • Evidence: Clinical work shows niacinamide significantly reduced hyperpigmentation and increased skin lightness versus vehicle after use, with mechanistic support for reduced melanosome transfer in a co-culture model.
  • PubMed: Hakozaki et al. (PMID: 12100180)
• Kojic Acid
  • What it supports: Helps improve the appearance of dark spots by influencing melanin-production pathways (often discussed via tyrosinase-related mechanisms).
  • Evidence: A clinical study found adding kojic acid to a gel with glycolic acid and hydroquinone further improved melasma appearance versus the regimen without kojic acid.
  • PubMed: Lim (PMID: 10417583)
• Azelaic Acid
  • What it supports: Helps improve the appearance of discoloration and uneven tone, and is often used in pigment-focused routines.
  • Evidence: A large double-blind study (329 women, 24 weeks) found 20% azelaic acid produced substantial improvement in melasma appearance and was comparable overall to 4% hydroquinone in that study.
  • PubMed: Baliña & Graupe (PMID: 1816137)
• 4-n-Butylresorcinol
  • What it supports: Helps improve the appearance of uneven pigmentation.
  • Evidence: A randomized, double-blind, vehicle-controlled split-face trial found 4-n-butylresorcinol 0.1% significantly reduced melanin index versus vehicle by weeks 4 and 8, and was well tolerated.
  • PubMed: Huh et al. (PMID: 20548876)
• Licorice Extract (Glabridin)
  • What it supports: Supports a more even-looking tone and helps calm visible inflammation that can accompany discoloration.
  • Evidence: Preclinical work found glabridin inhibited melanogenesis and tyrosinase activity in models (cell and guinea pig skin), supporting its role as a pigmentation modulator. A review of natural depigmenting ingredients summarizes licorice extract evidence and positioning.
  • PubMed: Yokota et al. (PMID: 9870547)| PubMed: Leyden et al. review (PMID: 21623927)
• Vitamin C (Ascorbic Acid)
  • What it supports: Antioxidant support plus improvement in the appearance of uneven tone, especially in photo-related discoloration contexts.
  • Evidence: A randomized controlled study evaluated an L-ascorbic acid plus phytic acid serum vs placebo on solar lentigines and reported depigmenting activity versus placebo.
  • PubMed: Khemis et al. (PMID: 22151934)
• Magnesium Ascorbyl Phosphate
  • What it supports: A vitamin C derivative often used to support a brighter, more even-looking tone.
  • Evidence: A clinical study in refractory melasma found a regimen using 5% magnesium ascorbyl phosphate (in combination with fluorescent pulsed light) was effective and well tolerated in that study context.
  • PubMed: Shaikh et al. (PMID: 24168559)
• Tetrahexyldecyl Ascorbate
  • What it supports: A lipophilic vitamin C derivative often used for antioxidant support and the appearance of uneven tone.
  • Evidence: An open-label clinical study of a serum containing tetrahexyldecyl ascorbate (in a multi-ingredient serum) reported improvement in photoaging appearance and uneven pigmentation.
  • PubMed: Min et al. (PMID: 38634176)
• Tranexamic Acid
  • What it supports: Helps improve the appearance of irregular pigmentation, often discussed for discoloration prone skin.
  • Evidence: A randomized, double-blind, vehicle-controlled trial found a formulation with niacinamide + tranexamic acid reduced the appearance of irregular pigmentation beyond sunscreen alone.
  • PubMed: Oh et al. (PMID: 24033822)
• Glutathione
  • What it supports: Antioxidant support and anti-melanogenic positioning in the hyperpigmentation literature.
  • Evidence: A 2024 review summarizes the clinical evidence and safety considerations for glutathione as a skin-lightening agent and in melasma.
  • PubMed: Sarkar et al. review (PMID: 39444151)
• Ascorbyl Glucoside
  • What it supports: A vitamin C derivative used to support brighter-looking skin tone.
  • Evidence: A placebo-controlled clinical study reported that an ascorbyl glucoside based complex improved hyperpigmentation levels of solar lentigines over time, with outcomes visible to subjects.
  • PMC: Takada et al. (PMCID: PMC11678523)
• Undecylenoyl Phenylalanine (1%)
  • What it supports: Helps improve the appearance of facial hyperpigmentation in clinical testing, and is often paired with niacinamide.
  • Evidence: Two double-blind split-face clinical studies found the combination of 5% niacinamide + 1% undecylenoyl phenylalanine was significantly more effective than vehicle and more effective than 5% niacinamide alone at reducing the appearance of facial hyperpigmentation after 8 weeks.
  • PubMed: Bissett et al., J Cosmet Dermatol (PMID: 19958429)

Why these work well together

This is a logical inference based on the mechanisms and outcomes described across the studies above. Hyperpigmentation is multi-factorial, so formulas that address more than one pathway often perform better in real-world use.

• Multiple pathways, not a single bottleneck: Some ingredients primarily influence melanin-production pathways, while others support reduced pigment transfer and improved skin appearance through complementary mechanisms.
• Combination evidence exists: There is direct clinical evidence that pairing ingredients with different mechanisms can outperform a single active (for example, niacinamide + undecylenoyl phenylalanine in a split-face design).
• Antioxidant support alongside tone actives: Vitamin C forms plus glutathione add antioxidant support, which is frequently used to complement pigmentation-focused actives in cosmetic routines.

Important context: Many studies above were conducted on facial skin, specific populations, and specific concentrations and formats. Individual results vary. Always use daily sun protection, since sun exposure can worsen the appearance of discoloration.